[HTML][HTML] The effect of pathophysiology on pharmacokinetics in the critically ill patient—concepts appraised by the example of antimicrobial agents

SI Blot, F Pea, J Lipman - Advanced drug delivery reviews, 2014 - Elsevier
Critically ill patients are at high risk for development of life-threatening infection leading to
sepsis and multiple organ failure. Adequate antimicrobial therapy is pivotal for optimizing the …

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

JA Roberts, MH Abdul-Aziz, J Lipman… - The Lancet infectious …, 2014 - thelancet.com
Infections in critically ill patients are associated with persistently poor clinical outcomes.
These patients have severely altered and variable antibiotic pharmacokinetics and are …

Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine …

AA Udy, JP Baptista, NL Lim, GM Joynt… - Critical care …, 2014 - journals.lww.com
Objective: To describe the prevalence and natural history of augmented renal clearance in a
cohort of recently admitted critically ill patients with normal plasma creatinine concentrations …

Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?

A Huttner, S Harbarth, WW Hope… - Journal of …, 2015 - academic.oup.com
Traditional antibiotic dosing was not designed for today's escalating antibiotic resistance,
lack of novel antibiotics and growing complexity in patient populations. Dosing that ensures …

Augmented renal clearance

AM Cook, J Hatton‐Kolpek - Pharmacotherapy: The Journal of …, 2019 - Wiley Online Library
Augmented renal clearance (ARC) is a phenomenon in critically ill patients characterized by
increased creatinine clearance and elimination of renally eliminated medications. Patients …

[HTML][HTML] A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia

MH Kollef, J Chastre, M Clavel, MI Restrepo, B Michiels… - Critical Care, 2012 - Springer
Introduction The aim of this study was to compare a 7-day course of doripenem to a 10-day
course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram …

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient …

MH Abdul-Aziz, J Lipman, M Akova… - Journal of …, 2016 - academic.oup.com
Objectives We utilized the database of the Defining Antibiotic Levels in Intensive care unit
patients (DALI) study to statistically compare the pharmacokinetic/pharmacodynamic and …

[HTML][HTML] Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy

J Mensa, J Barberán, A Soriano, P Llinares… - Revista Española de …, 2018 - ncbi.nlm.nih.gov
Pseudomonas aeruginosa is characterized by a notable intrinsic resistance to antibiotics,
mainly mediated by the expression of inducible chromosomic β-lactamases and the …

[HTML][HTML] Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients

AA Udy, JA Roberts, AF Shorr, RJ Boots, J Lipman - Critical Care, 2013 - Springer
Introduction Improved methods to optimize drug dosing in the critically ill are urgently
needed. Traditional prescribing culture involves recognition of factors that mandate dose …

[HTML][HTML] Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill …

DC Richter, O Frey, A Röhr, JA Roberts, A Köberer… - Infection, 2019 - Springer
Purpose Standard dosing and intermittent bolus application (IB) are important risk factors for
pharmacokinetic (PK) target non-attainment during empirical treatment with β-lactams in …